Cepheid (CPHD) - Product Pipeline Analysis

Cepheid (CPHD) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide88 Pages Price :
$ 750

Cepheid is a molecular diagnostic company. The company carries out the development, manufacture and marketing of fully-integrated molecular systems and tests for genetic analysis in the clinical, industrial and biothreat markets. These systems allow rapid and sophisticated genetic testing of organisms and genetic-based diseases. The company\'s product category includes systems, clinical IVD(in-vitro diagnostics) tests, RUO(research use only) products, ASR(analyte specific reagents) products, software, industrial reagents, parts and accessories and biothreat tests. The company\'s two major systems include the SmartCycler and GeneXpert. Cepheids operations are spread across North America, Europe, Africa and Asia. The company is headquartered in California, the US.

This report is a source for data, analysis and actionable intelligence on the Cepheid portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 6
List of Figures 8

Cepheid - Business Description 9

Key Facts 10
Cepheid - Major Products and Services 11
Cepheid Pipeline Products by Equipment Type 13
Cepheid Pipeline Products by Development Stage 16
Cepheid Pipeline Products by Therapy Area 19
Cepheid Pipeline Products by Trial Phase 22
Cepheid Pipeline Products by Milestone Summary 24
Vaginitis Panel Assay 26
Vaginitis Panel Assay Product Status 26
Vaginitis Panel Assay Product Description 26
Xpert BCR-ABL Monitor Test 27
Xpert BCR-ABL Monitor Test Product Status 27
Xpert BCR-ABL Monitor Test Product Description 27
Xpert BCR-ABL Monitor Test Product Milestone 27
Xpert BCR-ABL Monitor Test Clinical Trial 28
Xpert BCR-ABL Monitor V1 Test 30
Xpert BCR-ABL Monitor V1 Test Product Status 30
Xpert BCR-ABL Monitor V1 Test Product Description 30
Xpert BCR-ABL Monitor V2 Test 31
Xpert BCR-ABL Monitor V2 Test Product Status 31
Xpert BCR-ABL Monitor V2 Test Product Description 31
Xpert BKV Assay 32
Xpert BKV Assay Product Status 32
Xpert BKV Assay Product Description 32
Xpert BKV Assay Product Patent Details 32
Xpert Bladder Cancer Asymptomatic Assay 35
Xpert Bladder Cancer Asymptomatic Assay Product Status 35
Xpert Bladder Cancer Asymptomatic Assay Product Description 35
Xpert Bladder Cancer Monitor Test 36
Xpert Bladder Cancer Monitor Test Product Status 36
Xpert Bladder Cancer Monitor Test Product Description 36
Xpert Bladder Cancer Symptomatic Assay 37
Xpert Bladder Cancer Symptomatic Assay Product Status 37
Xpert Bladder Cancer Symptomatic Assay Product Description 37
Xpert Breast CA Rx Strat Assay 38
Xpert Breast CA Rx Strat Assay Product Status 38
Xpert Breast CA Rx Strat Assay Product Description 38
Xpert Breast Cancer Metastasis Risk Assay 39
Xpert Breast Cancer Metastasis Risk Assay Product Status 39
Xpert Breast Cancer Metastasis Risk Assay Product Description 39
Xpert Candidemia Assay 40
Xpert Candidemia Assay Product Status 40
Xpert Candidemia Assay Product Description 40
Xpert CMV Quant Assay 41
Xpert CMV Quant Assay Product Status 41
Xpert CMV Quant Assay Product Description 41
Xpert CMV Quant Assay Product Patent Details 41
Xpert CT/NG CLIA Waived Assay 44
Xpert CT/NG CLIA Waived Assay Product Status 44
Xpert CT/NG CLIA Waived Assay Product Description 44
Xpert CT/NG FluroQ Resistant Trichomonas Assay 45
Xpert CT/NG FluroQ Resistant Trichomonas Assay Product Status 45
Xpert CT/NG FluroQ Resistant Trichomonas Assay Product Description 45
Xpert CT/NG Test 46
Xpert CT/NG Test Product Status 46
Xpert CT/NG Test Product Description 46
Xpert CT/NG Test Product Milestone 47
Xpert EBV Quant Assay 48
Xpert EBV Quant Assay Product Status 48
Xpert EBV Quant Assay Product Description 48
Xpert EBV Quant Assay Product Patent Details 48
Xpert Gastro B Panel Assay 51
Xpert Gastro B Panel Assay Product Status 51
Xpert Gastro B Panel Assay Product Description 51
Xpert Group A Strep Assay 52
Xpert Group A Strep Assay Product Status 52
Xpert Group A Strep Assay Product Description 52
Xpert HBV Quant Assay 53
Xpert HBV Quant Assay Product Status 53
Xpert HBV Quant Assay Product Description 53
Xpert HCV Genotype Assay 54
Xpert HCV Genotype Assay Product Status 54
Xpert HCV Genotype Assay Product Description 54
Xpert HCV Quant Assay 55
Xpert HCV Quant Assay Product Status 55
Xpert HCV Quant Assay Product Description 55
Xpert HIV Quant Assay 56
Xpert HIV Quant Assay Product Status 56
Xpert HIV Quant Assay Product Description 56
Xpert HIV Quant Assay Product Patent Details 56
Xpert HIV Viral Load Test 59
Xpert HIV Viral Load Test Product Status 59
Xpert HIV Viral Load Test Product Description 59
Xpert HPV Assay 60
Xpert HPV Assay Product Status 60
Xpert HPV Assay Product Description 60
Xpert HSV CSF Assay 61
Xpert HSV CSF Assay Product Status 61
Xpert HSV CSF Assay Product Description 61
Xpert HSV Typing Lesion Test 62
Xpert HSV Typing Lesion Test Product Status 62
Xpert HSV Typing Lesion Test Product Description 62
Xpert Lung Cancer Assay 63
Xpert Lung Cancer Assay Product Status 63
Xpert Lung Cancer Assay Product Description 63
Xpert MDRO Assay 64
Xpert MDRO Assay Product Status 64
Xpert MDRO Assay Product Description 64
Xpert Microbial ID Assay 65
Xpert Microbial ID Assay Product Status 65
Xpert Microbial ID Assay Product Description 65
Xpert MRSA Next Generation Assay 66
Xpert MRSA Next Generation Assay Product Status 66
Xpert MRSA Next Generation Assay Product Description 66
Xpert MRSA/SA SSTI Test-CLIA Waived 67
Xpert MRSA/SA SSTI Test-CLIA Waived Product Status 67
Xpert MRSA/SA SSTI Test-CLIA Waived Product Description 67
Xpert MTB/RIF Assay 68
Xpert MTB/RIF Assay Product Status 68
Xpert MTB/RIF Assay Product Description 68
Xpert MTB/RIF Assay Product Milestone 69
Xpert Next Generation MRSA/SA BC Assay 70
Xpert Next Generation MRSA/SA BC Assay Product Status 70
Xpert Next Generation MRSA/SA BC Assay Product Description 70
Xpert Next Generation MRSA/SA SSTI Assay 71
Xpert Next Generation MRSA/SA SSTI Assay Product Status 71
Xpert Next Generation MRSA/SA SSTI Assay Product Description 71
Xpert Next Generation SA Nasal Complete Assay 72
Xpert Next Generation SA Nasal Complete Assay Product Status 72
Xpert Next Generation SA Nasal Complete Assay Product Description 72
Xpert Norovirus Assay 73
Xpert Norovirus Assay Product Status 73
Xpert Norovirus Assay Product Description 73
Xpert RSV Assay 74
Xpert RSV Assay Product Status 74
Xpert RSV Assay Product Description 74
Xpert RSV/Metapneumovirus Assay 75
Xpert RSV/Metapneumovirus Assay Product Status 75
Xpert RSV/Metapneumovirus Assay Product Description 75
Xpert Vaginosis Assay 76
Xpert Vaginosis Assay Product Status 76
Xpert Vaginosis Assay Product Description 76
Xpert VAP Gram Negative Assay 77
Xpert VAP Gram Negative Assay Product Status 77
Xpert VAP Gram Negative Assay Product Description 77
Xpert VAP MRSA/SA Assay 78
Xpert VAP MRSA/SA Assay Product Status 78
Xpert VAP MRSA/SA Assay Product Description 78
Xpert VZV Assay 79
Xpert VZV Assay Product Status 79
Xpert VZV Assay Product Description 79
Cepheid - Key Competitors 80
Cepheid - Key Employees 81
Cepheid - Key Employee Biographies 82
Cepheid - Locations And Subsidiaries 83
Head Office 83
Other Locations & Subsidiaries 83
Recent Developments 84
Cepheid, Recent Developments 84
Jul 19, 2012: Cepheid Reports Revenue Of $81m In Q2 2012 84
Apr 19, 2012: Cepheid Reports Revenue Of $77.3m In Q1 2012 84
Jan 26, 2012: Cepheid Reports Revenue Of $277.6m In 2011 84
Oct 20, 2011: Cepheid Reports Total Revenues Of $70.2m In Q3 2011 85
Jul 21, 2011: Cepheid Reports Total Revenues Of $67m In Q2 2011 85
Jun 29, 2011: \'Art Meets Innovation\' Event Teams Cepheid With Paul Jr Designs For Unveiling of New Products At 2011 AACC/ASCLS Meeting 86
Jun 22, 2011: Cepheid Appoints Robert Kwiatkowski As Vice President Of Infectious Disease R&D 86
May 18, 2011: Cepheid Signs Distribution Agreement With LABSCO In US 87
Apr 20, 2011: Cepheid Reports Total Revenues Of $60.2m In Q1 2011 87
Feb 28, 2011: Cepheid Appoints Michael Bates As Vice President Of Oncology Research And Development 87

Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88

List of Table


Cepheid, Key Facts 1
Cepheid Key Pipeline Products by Equipment Type 1
Cepheid Key Pipeline Products by Therapy Area 1
Cepheid Key Pipeline Products by Development Stage 1
Cepheid Key Pipeline Products by Trial Phase 1
Cepheid, Key Facts 10
Cepheid, Major Products and Services 11
Cepheid Number of Pipeline Products by Equipment Type 13
Cepheid Pipeline Products by Equipment Type 14
Cepheid Number of Pipeline Products by Development Stage 16
Cepheid Pipeline Products by Development Stage 17
Cepheid Number of Pipeline Products by Therapy Area 19
Cepheid Pipeline Products by Therapy Area 20
Cepheid Number of Pipeline Products by Trial Phase 22
Cepheid Pipeline Products by Trial Phase 23
Cepheid Number of Pipeline Products By Milestone Summary 24
Cepheid Pipeline Products by Milestone Summary 25
Vaginitis Panel Assay - Product Status 26
Vaginitis Panel Assay - Product Description 26
Xpert BCR-ABL Monitor Test - Product Status 27
Xpert BCR-ABL Monitor Test - Product Description 27
Xpert BCR-ABL Monitor Test - Product Milestone 27
Xpert BCR-ABL Monitor Test - Evaluation of the Xpert BCR-ABL Monitor assay for quantitative assessment of the BCR-ABL transcript in CML patients 28
Xpert BCR-ABL Monitor V1 Test - Product Status 30
Xpert BCR-ABL Monitor V1 Test - Product Description 30
Xpert BCR-ABL Monitor V2 Test - Product Status 31
Xpert BCR-ABL Monitor V2 Test - Product Description 31
Xpert BKV Assay - Product Status 32
Xpert BKV Assay - Product Description 32
Xpert BKV Assay - Patent Details1 32
Xpert BKV Assay - Patent Details2 33
Xpert BKV Assay - Patent Details3 33
Xpert BKV Assay - Patent Details4 34
Xpert Bladder Cancer Asymptomatic Assay - Product Status 35
Xpert Bladder Cancer Asymptomatic Assay - Product Description 35
Xpert Bladder Cancer Monitor Test - Product Status 36
Xpert Bladder Cancer Monitor Test - Product Description 36
Xpert Bladder Cancer Symptomatic Assay - Product Status 37
Xpert Bladder Cancer Symptomatic Assay - Product Description 37
Xpert Breast CA Rx Strat Assay - Product Status 38
Xpert Breast CA Rx Strat Assay - Product Description 38
Xpert Breast Cancer Metastasis Risk Assay - Product Status 39
Xpert Breast Cancer Metastasis Risk Assay - Product Description 39
Xpert Candidemia Assay - Product Status 40
Xpert Candidemia Assay - Product Description 40
Xpert CMV Quant Assay - Product Status 41
Xpert CMV Quant Assay - Product Description 41
Xpert CMV Quant Assay - Patent Details1 41
Xpert CMV Quant Assay - Patent Details2 42
Xpert CMV Quant Assay - Patent Details3 42
Xpert CMV Quant Assay - Patent Details4 43
Xpert CT/NG CLIA Waived Assay - Product Status 44
Xpert CT/NG CLIA Waived Assay - Product Description 44
Xpert CT/NG FluroQ Resistant Trichomonas Assay - Product Status 45
Xpert CT/NG FluroQ Resistant Trichomonas Assay - Product Description 45
Xpert CT/NG Test - Product Status 46
Xpert CT/NG Test - Product Description 46
Xpert CT/NG Test - Product Milestone 47
Xpert EBV Quant Assay - Product Status 48
Xpert EBV Quant Assay - Product Description 48
Xpert EBV Quant Assay - Patent Details1 48
Xpert EBV Quant Assay - Patent Details2 49
Xpert EBV Quant Assay - Patent Details3 49
Xpert EBV Quant Assay - Patent Details4 50

List of Chart


Cepheid Key Pipeline Products by Equipment Type 1
Cepheid Pipeline Products by Equipment Type 13
Cepheid Pipeline Products by Development Stage 16
Cepheid Pipeline Products by Therapy Area 19
Cepheid Pipeline Products by Trial Phase 22
Cepheid Pipeline Products by Milestone Summary 24

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top